Certified Global Research Member
Isomar fd.webp Wcrc 57.webp
Key Questions Answered
  • Global Market Outlook
  • In-depth analysis of global and regional trends
  • Analyze and identify the major players in the market, their market share, key developments, etc.
  • To understand the capability of the major players based on products offered, financials, and strategies.
  • Identify disrupting products, companies, and trends.
  • To identify opportunities in the market.
  • Analyze the key challenges in the market.
  • Analyze the regional penetration of players, products, and services in the market.
  • Comparison of major players’ financial performance.
  • Evaluate strategies adopted by major players.
  • Recommendations
Why Choose Market Research Future?
  • Vigorous research methodologies for specific market.
  • Knowledge partners across the globe
  • Large network of partner consultants.
  • Ever-increasing/ Escalating data base with quarterly monitoring of various markets
  • Trusted by fortune 500 companies/startups/ universities/organizations
  • Large database of 5000+ markets reports.
  • Effective and prompt pre- and post-sales support.

MEA Ischemic Heart Disease Companies

Companies in the Middle East and Africa focusing on ischemic heart disease contribute to cardiovascular health by providing diagnostic tools, medications, and interventions for individuals with conditions like coronary artery disease. These companies play a key role in addressing the challenges posed by ischemic heart disease, including ischemic events and heart attacks, through innovative medical solutions.

Middle-East and Africa Ischemic heart Disease


Latest Middle-East and Africa Ischemic heart Disease Companies Updates:

Johnson & Johnson Partnered with local hospitals in Saudi Arabia and South Africa to launch educational programs for healthcare professionals on the latest IHD treatment advancements.Invested in expanding their distribution network for cardiovascular medical devices in Egypt and Morocco.

Philips Healthcare Collaborated with the government of Qatar to equip public hospitals with advanced cardiac imaging systems for early IHD detection and improved diagnosis.Introduced their latest robotic-assisted angioplasty technology in select hospitals in UAE and Kenya.

Abbott Laboratories Received regulatory approval in UAE and South Africa for their Absorb™ BVS (Bioresorbable Vascular Scaffold), offering a minimally invasive option for treating peripheral artery disease, a common complication of IHD.Partnered with non-profit organizations in Kenya and Nigeria to provide access to affordable IHD medications for underserved communities.

Siemens Healthineers Established a training center in Dubai to provide cardiac surgeons and interventional cardiologists in the region with hands-on training on advanced IHD treatment techniques.Collaborated with universities in Egypt and Ghana to develop research programs on IHD prevention and management in MENA and Africa.

Medtronic plcLaunched their Resolute™ Onyx DES with a unique drug delivery system in several major hospitals across MENA, potentially reducing drug exposure and related side effects for IHD patients.Partnered with a telemedicine startup in South Africa to expand remote access to IHD consultations and specialist care in rural areas.

List of Middle-East and Africa Ischemic heart Disease Key companies in the market

  • King Faisal Specialist Hospital and Research Centre (Saudi Arabia),

  • Riyadh Military Hospital (Saudi Arabia),

  • Hamad Medical Corporation (Qatar),

  • American Hospital Dubai,

  • Ganzouri Specialized Hospital (Egypt),

  • AstraZeneca (U.K.), Sanofi (France),

  • Merck Sharp & Dohme Corp. (U.S.),

  • AUM Cardiovascular (US),

  • HeartWare (U.S.)

Leading companies partner with us for data-driven Insights
client_1 client_2 client_3 client_4 client_5 client_6 client_7 client_8 client_9 client_10
Kindly complete the form below to receive a free sample of this Report
Please fill in Business Email for Quick Response

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

Purchase Option
Single User $ 4,950
Multiuser License $ 5,950
Enterprise User $ 7,250
Compare Licenses
Tailored for You
  • Dedicated Research on any specifics segment or region.
  • Focused Research on specific players in the market.
  • Custom Report based only on your requirements.
  • Flexibility to add or subtract any chapter in the study.
  • Historic data from 2014 and forecasts outlook till 2040.
  • Flexibility of providing data/insights in formats (PDF, PPT, Excel).
  • Provide cross segmentation in applicable scenario/markets.